Home > News > 454 Life Sciences Receives $2.4 million NIH Grant
May 19th, 2004
454 Life Sciences Receives $2.4 million NIH Grant
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation today announced that the Company has received a two-year, $2.4 million grant from the National Human Genome Research Institute, one of the National Institutes of Health. The grant will help fund the scale up of 454 Life Sciences' technology toward sequencing of larger genomes.
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014